Abata Therapeutics
Abata Therapeutics is a startup headquartered in Watertown, United States, founded in 2020. It has raised at least $15.3m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Abata Therapeutics has raised at least $15.3m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Abata Therapeutics sits inside the Boston and New England R&D ecosystem in the Global R&D Labs Directory.
Other startups in Watertown
- Affini-T Therapeutics
- Averna Therapeutics
- Corner Therapeutics
- Elastro
- EnPlusOne Biosciences
- Entact Bio
- Multitude Insights
- PathCision Medicine
- Remix Therapeutics
- Treeline Biosciences
- Tutor Intelligence
Related
Questions and answers
What does Abata Therapeutics do?
Abata Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Abata Therapeutics raised?
At least $15.3m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Abata Therapeutics based?
Abata Therapeutics is headquartered in Watertown, United States.
When was Abata Therapeutics founded?
Abata Therapeutics was founded in 2020.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.